Adagene Total Non Current Liabilities 2011-2026 | ADAG

Annual Total Non Current Liabilities Adagene

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	158 M	156 M	85.1 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
158 M	85.1 M	133 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	79.1 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	158 K	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	69.4 M	$ 16.88	-2.43 %	$ 789 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Compugen Ltd. CGEN	31.3 M	$ 2.79	-8.09 %	$ 261 M	Israel
Coherus BioSciences CHRS	189 M	$ 1.6	-2.15 %	$ 187 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	34.7 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 7.56	-3.45 %	$ 207 M	Israel
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	7.32 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	64 M	-	-32.59 %	$ 7.61 M	USA
Esperion Therapeutics ESPR	355 M	$ 3.13	0.32 %	$ 651 M	USA
Exelixis EXEL	63.6 M	$ 50.41	-1.36 %	$ 13.7 B	USA
Fortress Biotech FBIO	83.9 M	$ 2.43	5.65 %	$ 67.8 M	USA
Midatech Pharma plc MTP	645 K	-	-18.52 %	$ 27.3 M	Britain
Forte Biosciences FBRX	10.5 M	$ 23.1	-3.57 %	$ 299 M	USA
Fennec Pharmaceuticals FENC	24.6 M	$ 9.76	5.63 %	$ 279 M	USA
AbCellera Biologics ABCL	326 M	$ 4.09	-7.05 %	$ 1.22 B	Canada
Autolus Therapeutics plc AUTL	50.6 M	$ 1.59	-	$ 423 M	Britain
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
BioNTech SE BNTX	622 M	$ 89.16	-3.08 %	$ 21.5 B	Germany
Galectin Therapeutics GALT	52 K	$ 2.22	-5.74 %	$ 142 M	USA
Gilead Sciences GILD	29.2 B	$ 130.07	-1.51 %	$ 162 B	USA
Genmab A/S GMAB	769 M	$ 26.8	-0.37 %	$ 1.73 B	Danmark
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.41	-2.25 %	$ 5.61 M	Israel
Aeterna Zentaris AEZS	14 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Grifols, S.A. GRFS	10.6 B	$ 7.74	-0.64 %	$ 5.26 B	Spain
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	383 M	$ 0.72	-1.05 %	$ 32.9 M	Israel
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Eton Pharmaceuticals ETON	4.56 M	$ 29.69	-0.92 %	$ 799 M	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 21.51	-0.3 %	$ 2.74 B	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA